Selective B-cell subset depletion underlies increased infection risk in patients with MM treated with anti-BCMA vs anti-GPRC5D bsAbs.

Blood · 2026 · PMC13014095 · PMID 41405507

Europe PMC DOI

hedged sentence

0.0870

closest p · 1.7× alpha

0.0870

boldest claim

The sentences

borderline significantP = .087so close (0.05 < p ≤ 0.1)

There was a borderline significant difference toward greater depletion of B-cell precursors during treatment in the BCMA vs GPRC5D groups ( P = .087; supplemental Figure 9 ).

also in 11,409 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.